MedTrace Logo

Optimal Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in Adults

NCT03228862 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2017-07-26

No results posted yet for this study

Summary

To investigate the optimal initial and maintenance doses of vitamin D2 supplementation for the treatment of vitamin D insufficiency in Thai adults, and to determine the prevalence of and risk factors for hypovitaminosis D among Thai adults.

Conditions

  • Vitamin D2 Supplementation in Vitamin D Insufficiency

Interventions

DRUG

Ergocalciferol

Ergocalciferol 40000, 60000 and 80000 once weekly

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2018-02-01
Completion
2018-02-01

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03228862 on ClinicalTrials.gov